Centrum Zdrowia Psychicznego Biomed - Jan Latala
- Address
- Ul. Szydlowek Gorny1c/3, 25-411 Kielce, Poland
Centrum Zdrowia Psychicznego Biomed - Jan Latala
Centrum Zdrowia Psychicznego Biomed - Jan Latala is a specialized psychiatric research facility dedicated to advancing the understanding and treatment of mental health disorders. The center focuses on conducting rigorous clinical trials that evaluate innovative therapeutic approaches for psychiatric conditions, with particular expertise in pharmacological interventions and personalized medicine approaches.
- Major Depressive Disorder treatment research and novel antidepressant development
- Precision psychiatry utilizing polygenic scoring and biomarker-driven patient selection
- Multi-phase clinical trials for psychiatric medications with comprehensive efficacy and safety assessments
The center demonstrates advanced capabilities in conducting placebo-controlled, double-blind studies that incorporate modern genetic stratification methods. Their research infrastructure supports comprehensive evaluation of depressive symptomatology and treatment response in outpatient populations, contributing to the development of targeted therapies for patients with Major Depressive Disorder. The facility's commitment to precision medicine approaches, including the use of V1b polygenic scoring, positions them at the forefront of personalized psychiatric treatment development.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Zdrowia Psychicznego Biomed - Jan Latala
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Tolerability of BH-200 (Nelivaptan) in V1b-High Outpatients with Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase II Study | HMNC Holding GmbH | Phase II | Not Recruiting | Nov 2024 | Apr 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid | 1 | Unknown | 2024-06-13 | 2024-06-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.